Back to Search
Start Over
Perfil clínico-epidemiológico de las defunciones por influenza con antecedente de vacunación oportuna, México 2010-2018
- Source :
- Gaceta Médica de México. 155
- Publication Year :
- 2019
- Publisher :
- Publicidad Permanyer, SLU, 2019.
-
Abstract
- espanolIntroduccion: Las epidemias de influenza son de mayor riesgo en los extremos de la vida y en personas con comorbilidades. La vacunacion efectiva previene la aparicion de casos graves y disminuye la mortalidad. Objetivo: Describir las defunciones por influenza en Mexico con antecedente de vacunacion oportuna, de 2010 a 2018. Metodo: Estudio transversal descriptivo en el que se utilizo la base de datos del Sistema de Vigilancia Epidemiologica de Influenza. Resultados: De 2010 a 2018 fallecieron por influenza 65 personas con vacunacion, 55 % (n = 36) de las cuales por tipo A (H1N1), 51 % (n = 33) del sexo femenino, la mediana de edad fue de 57 anos, 21 % (n = 14) no cumplia la definicion operacional de enfermedad tipo influenza o infeccion respiratoria aguda grave, 83 % (n = 54) tenia al menos una comorbilidad; las comorbilidades mas frecuentes fueron diabetes mellitus e hipertension arterial (32 % cada una); 55 % (n = 36) recibio tratamiento antiviral y solo 8 % (n = 5) no presentaba comorbilidades y tenia tratamiento con oseltamivir. Conclusiones: Las defunciones por influenza con vacunacion oportuna representan un porcentaje muy bajo del total. La vacunacion contra influenza ha sido una estrategia de prevencion especifica que disminuye la carga de la enfermedad. EnglishIntroduction: Influenza epidemics are of higher risk at the extremes of life and in people with comorbidities. Effective vaccination prevents the occurrence of serious cases and decreases mortality. Objective: To describe deaths from influenza with a history of timely vaccination, from the 2010 to the 2018 season in Mexico. Method: Cross-sectional, descriptive study where the Influenza Epidemiological Surveillance System database was used. Results: From 2010 to 2018, 65 vaccinated individuals died from influenza, from which 55% of cases (n = 36) were due to type A (H1N1), 51% (n = 33) were females, median age was 57 years, 21 % (n = 14) did not meet the operational definition of influenza-like illness or severe acute respiratory infection, 83% (n = 54) had at least one comorbidity, with the most common being diabetes mellitus and hypertension (32% each); 55% (n = 36) of deaths received antiviral treatment and only 8% (n = 5) had no comorbidities and received treatment with oseltamivir. Conclusions: Deaths from influenza with timely vaccination represent a very low percentage of the totality. Vaccination against influenza has been a specific prevention strategy that decreases disease burden.
- Subjects :
- Male
medicine.medical_specialty
Oseltamivir
Influenza epidemics
Comorbidity
Antiviral Agents
03 medical and health sciences
chemistry.chemical_compound
Influenza A Virus, H1N1 Subtype
0302 clinical medicine
Severe acute respiratory infection
Influenza, Human
Infeccion respiratoria
Diabetes Mellitus
medicine
Humans
030212 general & internal medicine
Sex Distribution
Antiviral treatment
Mexico
Gynecology
business.industry
Vaccination
Estudio transversal
virus diseases
General Medicine
Middle Aged
Cross-Sectional Studies
chemistry
Influenza Vaccines
Hypertension
Epidemiological surveillance
Female
business
Subjects
Details
- ISSN :
- 00163813
- Volume :
- 155
- Database :
- OpenAIRE
- Journal :
- Gaceta Médica de México
- Accession number :
- edsair.doi.dedup.....69177907d196f1cee5214f6342db3c32